| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/25/2013 | EP2675481A1 Cytotoxic benzodiazepine derivatives and methods of preparation |
| 12/25/2013 | EP2675480A1 Methods of preparation of conjugates |
| 12/25/2013 | EP2675479A1 Cytotoxic benzodiazepine derivatives |
| 12/25/2013 | EP2675469A2 Compositions, devices and methods of use thereof for the treatment of cancers |
| 12/25/2013 | EP2675468A1 Method for treating breast cancer by decreasing the expression of adenine nucleotide translocator 2 mrna |
| 12/25/2013 | EP2675451A1 mTOR/JAK INHIBITOR COMBINATION THERAPY |
| 12/25/2013 | EP2523958B1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 12/25/2013 | EP2516442B1 Pyrrolo[2,3-d]pyrazin-7-yl pyrimidine compounds |
| 12/25/2013 | EP2483278B1 Benzoxazepin pi3k inhibitor compounds and their use in the treatment of cancer |
| 12/25/2013 | EP2406266B1 7-cycloalkylaminoquinolones as gsk-3 inhibitors |
| 12/25/2013 | EP2358703B1 Tetrasubstituted pyridazines hedgehog pathway antagonists |
| 12/25/2013 | EP2208721B1 Histone deacetylase inhibitor, composition and use thereof |
| 12/25/2013 | EP2097394B1 1,2,4-triazole derivatives as sigma receptor inhibitors |
| 12/25/2013 | EP2068871B1 Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and the use for nonsense suppression |
| 12/25/2013 | EP2056827B1 Method for inducing tumor apoptosis by increasing nitric oxide levels |
| 12/25/2013 | EP2043653B1 Crystalline forms of gemcitabine amide prodrug, compositions and use thereof |
| 12/25/2013 | EP2016952B1 A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
| 12/25/2013 | EP1999148B1 Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 12/25/2013 | EP1998799B1 Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 12/25/2013 | EP1997884B1 Novel human t cell population |
| 12/25/2013 | EP1991554B1 Thiopyrophosphate organic compounds, method for preparing thereof and compositions containing them |
| 12/25/2013 | CN1856323B Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in treatment of cancers |
| 12/25/2013 | CN103477228A Novel pancreatic cancer biomarker using the characteristics of pancreatic cancer stem cells, and use thereof |
| 12/25/2013 | CN103476801A Cellulose-based nanoparticles for drug delivery |
| 12/25/2013 | CN103476794A Antibody against the CSF-1R |
| 12/25/2013 | CN103476777A Novel heterocyclic derivatives |
| 12/25/2013 | CN103476776A 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitors |
| 12/25/2013 | CN103476773A New azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors |
| 12/25/2013 | CN103476770A Novel salts and polymorphic forms of afatinib |
| 12/25/2013 | CN103476769A Novel anti-cancer agents |
| 12/25/2013 | CN103476768A 6,5-heterocyclic propargylic alcohol compounds and uses therefor |
| 12/25/2013 | CN103476765A Method of inhibiting hamartoma tumor cells |
| 12/25/2013 | CN103476759A Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines |
| 12/25/2013 | CN103476755A Compounds and methods |
| 12/25/2013 | CN103476752A Substituted aromatic sulfur compounds and methods of their use |
| 12/25/2013 | CN103476434A Lutetium-177-labeled bombesin analogs for radiotherapy |
| 12/25/2013 | CN103476433A Improved immunotherapy |
| 12/25/2013 | CN103476430A Dosing for treatment with anti-EGFl7 antibodies |
| 12/25/2013 | CN103476411A Targeting human thymidylate kinase induces dna repair toxicity in malignant tumor cells |
| 12/25/2013 | CN103476407A Treatment of HER2-positive cancer with paclitaxel and trastuzumab-MCC-DM1 |
| 12/25/2013 | CN103468786A Uses and relevant drugs of human CDKL3 (cyclin-dependent kinase-like 3) gene |
| 12/25/2013 | CN103468785A Uses and relevant drugs of human SEMA4C (semaphorin 4C) gene |
| 12/25/2013 | CN103468778A Method for extracting 5alpha,8alpha-epidioxy-24(R)-methylsteroid-6,22-dialkylene-3beta-ol from Moelleriella |
| 12/25/2013 | CN103467729A Polyethylene glycol-poly amino acid-polyester triblock polymer, preparation method and use thereof |
| 12/25/2013 | CN103467613A Preparation method and product of agaricus blazeimurill (ABM) compound polysaccharide |
| 12/25/2013 | CN103467602A Compositions and methods for regulating NK cell activity |
| 12/25/2013 | CN103467590A Biological couplet, purine compounds for preparing biological couplet, synthetic method for preparing biological couplet, pharmaceutical preparation prepared from biological couplet and application of biological couplet in immune adjustment |
| 12/25/2013 | CN103467588A Stabilized alpha helical peptides and uses thereof |
| 12/25/2013 | CN103467565A Boronate ester compounds and pharmaceutical compositions thereof |
| 12/25/2013 | CN103467560A Preparation of novel asiatic acid derivative and application thereof in antitumor drugs |
| 12/25/2013 | CN103467552A 8-cyclohexyl-2-fluoro-vidarabine as well as preparation method and application thereof |
| 12/25/2013 | CN103467550A 5-cyclohexyl uracil arabinoside, preparation method and application thereof |
| 12/25/2013 | CN103467549A Sulfur-bearing uridine anticancer drug, intermediate and synthesis method |
| 12/25/2013 | CN103467526A Organic metallic platinum compound capable of inhibiting cancer cell proliferation, and synthetic method thereof |
| 12/25/2013 | CN103467521A Solid pharmaceutic preparation of dehydrated andrographolide phosphate sodium salt hydrate |
| 12/25/2013 | CN103467516A Golden phosphorous acetyletic compound, and preparation method and applications thereof |
| 12/25/2013 | CN103467512A Large-ring two-dimensional net structured tributyltin pyromellitic acid ester as well as preparation method and application thereof |
| 12/25/2013 | CN103467511A Large-ring structured tributyltin 9-anthracenecarboxylic acid ester as well as preparation method and application thereof |
| 12/25/2013 | CN103467497A Double-ligand copper complex with salicylidene-taurine and imidazole as ligands as well as synthesis method and application thereof |
| 12/25/2013 | CN103467482A Condensed pyrimidine compound, and preparation method, intermediate, composition and application thereof |
| 12/25/2013 | CN103467481A Dihydropyridine compounds, compositions thereof, preparation method and applications |
| 12/25/2013 | CN103467479A Spirocyclic compounds and compositions thereof, and preparation methods and uses thereof |
| 12/25/2013 | CN103467477A Procyanidin A2, and preparation method and application thereof |
| 12/25/2013 | CN103467476A Resveratrol trimer stilbene compounds, and preparation methods and uses thereof |
| 12/25/2013 | CN103467474A 1,6,7,14-substituted oridonin derivatives, as well as preparation method and application thereof |
| 12/25/2013 | CN103467470A Ocycloimino sugar compound and intermediate, medicament, preparation method and application thereof |
| 12/25/2013 | CN103467463A Lignin derivatives as well as preparation method and use thereof |
| 12/25/2013 | CN103467456A 3,5-disubstituted indolone derivatives and their preparation method and use |
| 12/25/2013 | CN103467454A Spiro substituted compounds as angiogenesis inhibitors |
| 12/25/2013 | CN103467452A Benzamide compounds and application thereof |
| 12/25/2013 | CN103467426A Quercetin hydrocarbylation derivative and preparation method and application thereof |
| 12/25/2013 | CN103467421A Application of radix stemonae sessilifoliae non-alkaloid extract and monomers to preparation of antitumor drug |
| 12/25/2013 | CN103467416A Crystalline form of cabazitaxel and preparation method thereof |
| 12/25/2013 | CN103467415A Crystalline form of cabazitaxel and preparation method thereof |
| 12/25/2013 | CN103467414A Crystalline form of cabazitaxel pyridine compound |
| 12/25/2013 | CN103467397A Binuclear platinum (II) complex as well as preparation method and application thereof |
| 12/25/2013 | CN103467385A Monocyclic heteroaryl compounds |
| 12/25/2013 | CN103467368A Medical application of N-pyridine methyl/ methoxyl-2-phenoxyl amide |
| 12/25/2013 | CN103467359A Cinnamon amides histone deacetylase inhibitor with benzpyrole and preparation method and application of same |
| 12/25/2013 | CN103467356A Tetrahydroindole compound, and preparation method and application thereof |
| 12/25/2013 | CN103467320A 2,5-disubstituted cyclopentanone derivatives and applications thereof |
| 12/25/2013 | CN103467293A Novel compound and application thereof in pharmaceuticals, food or cosmetics with anti-tumor function |
| 12/25/2013 | CN103467258A Lignanoid compound, and preparation method and use thereof |
| 12/25/2013 | CN103463646A Application of E2F1 protein in preparation of medicine for diagnosing and treating osteosarcoma |
| 12/25/2013 | CN103463644A Preparation method of allyl isothiocyanate-beta-cyclodextrin clathrate compound |
| 12/25/2013 | CN103463643A Preparation and application of human serum albumin-ruthenium inorganic medicine compound |
| 12/25/2013 | CN103463642A Preparation and application of human serum albumin-ruthenium inorganic medicine compound |
| 12/25/2013 | CN103463641A Preparation and application of human serum albumin-ruthenium inorganic medicine compound |
| 12/25/2013 | CN103463633A Targeting chimeric hepatitis B core antigen therapeutic vaccine and uses thereof |
| 12/25/2013 | CN103463631A B cell vaccine based on Hepal-6 hepatoma cell autophagosome-DRibbles and preparation method of B cell vaccine |
| 12/25/2013 | CN103463630A Concurrent chemotherapy and immunotherapy |
| 12/25/2013 | CN103463623A Pegylated interferon injection and preparation method thereof |
| 12/25/2013 | CN103463621A NA+/K+-Atpase-specific peptide inhibitors/activators of Src and Src family kinases |
| 12/25/2013 | CN103463619A Application of bone morphogenetic protein 4 in cancer inhibition |
| 12/25/2013 | CN103463617A Method for synthesizing targeting radioiodine labeled thyroglotulin nano capsule |
| 12/25/2013 | CN103463603A Smokeless traditional Chinese medicine moxibustion-therapic medicament and preparation method thereof |
| 12/25/2013 | CN103463602A Medicine for treating cutaneous squamous cell carcinoma and preparation method of medicine for treating cutaneous squamous cell carcinoma |
| 12/25/2013 | CN103463581A Preparation method and application of cholagogic and lithagogue tablet |
| 12/25/2013 | CN103463565A Zedoary oil injection and preparation method thereof |
| 12/25/2013 | CN103463554A Pharmaceutical composition for treating malignant tumor, preparation method and application |